Heartland Advisors Inc. Continues to Hold Stake in Safeguard Scientifics Inc. (SFE)
Heartland Advisors Inc. continued to hold its position in shares of Safeguard Scientifics Inc. (NYSE:SFE) during the third quarter, according to its most recent disclosure with the SEC. The fund owned 400,000 shares of the company’s stock at the end of the third quarter. Heartland Advisors Inc. owned 1.96% of Safeguard Scientifics worth $5,184,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. KBC Group NV increased its position in shares of Safeguard Scientifics by 112.7% in the second quarter. KBC Group NV now owns 8,465 shares of the company’s stock worth $106,000 after buying an additional 4,486 shares during the period. PineBridge Investments L.P. increased its position in shares of Safeguard Scientifics by 50.4% in the second quarter. PineBridge Investments L.P. now owns 8,591 shares of the company’s stock worth $107,000 after buying an additional 2,880 shares during the period. Alliancebernstein L.P. purchased a new position in shares of Safeguard Scientifics during the second quarter worth about $129,000. Neuberger Berman Group LLC purchased a new position in shares of Safeguard Scientifics during the second quarter worth about $131,000. Finally, LaSalle Street Capital Management LLC increased its position in shares of Safeguard Scientifics by 2.5% in the second quarter. LaSalle Street Capital Management LLC now owns 11,714 shares of the company’s stock worth $146,000 after buying an additional 287 shares during the period. Hedge funds and other institutional investors own 79.56% of the company’s stock.
Safeguard Scientifics Inc. (NYSE:SFE) traded down 0.183% during mid-day trading on Monday, hitting $12.028. 14,247 shares of the stock traded hands. Safeguard Scientifics Inc. has a 1-year low of $10.60 and a 1-year high of $16.48. The company has a 50-day moving average of $12.29 and a 200 day moving average of $12.95. The firm’s market capitalization is $243.42 million.
Safeguard Scientifics (NYSE:SFE) last posted its quarterly earnings data on Thursday, October 27th. The company reported ($1.18) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.74) by $0.44. During the same period in the prior year, the company posted ($0.56) EPS. On average, equities research analysts anticipate that Safeguard Scientifics Inc. will post ($0.34) EPS for the current year.
Separately, Zacks Investment Research lowered shares of Safeguard Scientifics from a “buy” rating to a “hold” rating in a research note on Saturday, October 29th.
In other Safeguard Scientifics news, CEO Stephen T. Zarrilli purchased 3,900 shares of Safeguard Scientifics stock in a transaction on Wednesday, September 14th. The shares were acquired at an average cost of $12.75 per share, for a total transaction of $49,725.00. Following the completion of the transaction, the chief executive officer now directly owns 103,606 shares of the company’s stock, valued at $1,320,976.50. The purchase was disclosed in a filing with the SEC, which is available at this link. 2.67% of the stock is currently owned by corporate insiders.
About Safeguard Scientifics
Safeguard Scientifics, Inc provides capital, as well as strategic, operational and management resources to growth-stage businesses. The Company participates in early- and growth-stage financings. The Company operates through two segments: Healthcare and Technology. The Healthcare segment’s companies focuses principally on medical technology (MedTech), including diagnostics and devices, and healthcare technology (HealthTech).
Receive News & Stock Ratings for Safeguard Scientifics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics Inc. and related stocks with our FREE daily email newsletter.